BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21910767)

  • 1. A transgenic approach to identify thyroxine transporter-expressing structures in brain development.
    Lang MF; Salinin S; Ridder DA; Kleesiek J; Hroudova J; Berger S; Schütz G; Schwaninger M
    J Neuroendocrinol; 2011 Dec; 23(12):1194-203. PubMed ID: 21910767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier.
    Roberts LM; Woodford K; Zhou M; Black DS; Haggerty JE; Tate EH; Grindstaff KK; Mengesha W; Raman C; Zerangue N
    Endocrinology; 2008 Dec; 149(12):6251-61. PubMed ID: 18687783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice expressing Cre-recombinase specifically in retinal rod bipolar neurons.
    Zhang XM; Chen BY; Ng AH; Tanner JA; Tay D; So KF; Rachel RA; Copeland NG; Jenkins NA; Huang JD
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3515-20. PubMed ID: 16186328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mart-1::Cre transgenic line induces recombination in melanocytes and retinal pigment epithelium.
    Aydin IT; Beermann F
    Genesis; 2011 May; 49(5):403-9. PubMed ID: 21309074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
    Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI
    Physiol Genomics; 2002 Sep; 10(3):211-5. PubMed ID: 12209023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a mouse line expressing Cre recombinase in glycinergic interneurons.
    Ishihara N; Armsen W; Papadopoulos T; Betz H; Eulenburg V
    Genesis; 2010 Jul; 48(7):437-45. PubMed ID: 20506101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell-specific expression of Cre recombinase in transgenic mice.
    Li WL; Cheng X; Tan XH; Zhang JS; Sun YS; Chen L; Yang X
    Yi Chuan Xue Bao; 2005 Sep; 32(9):909-15. PubMed ID: 16201233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain.
    Mayerl S; Visser TJ; Darras VM; Horn S; Heuer H
    Endocrinology; 2012 Mar; 153(3):1528-37. PubMed ID: 22294745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral-mediated Cre expression effectively suppresses GlyT1 binding in the thalamic area of GlyT1 conditional knock-out mice.
    Cazzin C; Zanderigo F; Costantini VJ; Zambello E; Ring CJ; Morrison AD; Caberlotto L; Kew JN
    J Neurosci Methods; 2010 Nov; 193(2):254-63. PubMed ID: 20832426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice.
    Iwasato T; Nomura R; Ando R; Ikeda T; Tanaka M; Itohara S
    Genesis; 2004 Mar; 38(3):130-8. PubMed ID: 15048810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of transgenic mice expressing Cre recombinase under the control of the Dll1 mesoderm enhancer element.
    Wehn AK; Gallo PH; Chapman DL
    Genesis; 2009 May; 47(5):309-13. PubMed ID: 19298012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
    Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
    Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A-iCre, a new transgenic mouse line for genetic analyses of the serotonergic pathway.
    Sahly I; Fabre V; Vyas S; Milet A; Rouzeau JD; Hamon M; Lazar M; Tronche F
    Mol Cell Neurosci; 2007 Sep; 36(1):27-35. PubMed ID: 17656109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
    Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
    Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier.
    Tohyama K; Kusuhara H; Sugiyama Y
    Endocrinology; 2004 Sep; 145(9):4384-91. PubMed ID: 15166123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies.
    Luche H; Weber O; Nageswara Rao T; Blum C; Fehling HJ
    Eur J Immunol; 2007 Jan; 37(1):43-53. PubMed ID: 17171761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron-specific recombination by Cre recombinase inserted into the murine tau locus.
    Muramatsu K; Hashimoto Y; Uemura T; Kunii M; Harada R; Sato T; Morikawa A; Harada A
    Biochem Biophys Res Commun; 2008 Jun; 370(3):419-23. PubMed ID: 18381201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of cells expressing human renin-promoter activity in the brain of a transgenic mouse.
    Allen AM; O'Callaghan EL; Hazelwood L; Germain S; Castrop H; Schnermann J; Bassi JK
    Brain Res; 2008 Dec; 1243():78-85. PubMed ID: 18840419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.